Aadi Bioscience, Inc. (AADI)
USD 2.29
(-4.18%)
USD 2.29
(-4.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 24.35 Million | 15.21 Million | 1 Million | 14 Million | 749 Thousand | 20.15 Million |
| Cost of Revenue | 2.8 Million | 1.33 Million | 276 Thousand | 176 Thousand | 76.5 Thousand | - |
| Gross Profit | 21.54 Million | 13.88 Million | 724 Thousand | 13.82 Million | 672.49 Thousand | 20.15 Million |
| Operating Expenses | 93.47 Million | 72.83 Million | 38.06 Million | 16.54 Million | 22.5 Million | 31.29 Million |
| Selling, General and Administrative Expenses | 44.54 Million | 40.17 Million | 18.51 Million | 2.12 Million | 9.67 Million | 13.43 Million |
| Research and Development Expenses | 48.92 Million | 32.66 Million | 19.67 Million | 15 Million | 12.82 Million | 17.85 Million |
| Other Expenses | - | 5.05 Million | -120 Thousand | -580 Thousand | -142.72 Thousand | -6394.00 |
| Cost and Expenses | 96.28 Million | 74.17 Million | 38.06 Million | 16.54 Million | 22.58 Million | 31.33 Million |
| Operating Income | -71.93 Million | -58.95 Million | -111.21 Million | -2.54 Million | -22.58 Million | -11.18 Million |
| Interest Expense | 231 Thousand | 230 Thousand | 665 Thousand | 815 Thousand | - | 778.21 Thousand |
| Income Tax Expense | - | -3.5 Million | 2000.00 | 2000.00 | 1300.00 | 778.21 Thousand |
| Earnings before Tax | -65.76 Million | -60.51 Million | -110.08 Million | -3.47 Million | -23.27 Million | -10.39 Million |
| Net Income | -65.76 Million | -57.01 Million | -110.09 Million | -3.47 Million | -23.27 Million | -10.39 Million |
| Earnings Per Share Basic | -2.44 | -2.53 | -12.34 | -20.52 | -8.60 | -4.60 |
| Earnings Per Share Diluted | -2.44 | -2.53 | -12.34 | -20.52 | -8.60 | -4.60 |
| Weighted Average Shares Outstanding | 26.91 Million | 22.51 Million | 8.92 Million | 169.49 Thousand | 2.7 Million | 2.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 26.91 Million | 22.51 Million | 8.92 Million | 169.49 Thousand | 2.7 Million | 2.26 Million |
| Gross Margin | 0.88 | 0.91 | 0.72 | 0.99 | 0.90 | 1.00 |
| EBIT Margin | -2.68 | -3.72 | -35.46 | -0.19 | -30.05 | -0.55 |
| Profit Margin | -2.70 | -3.75 | -110.09 | -0.25 | -31.07 | -0.52 |
| EBITDA | -65.36 Million | -60.12 Million | -109.14 Million | -2.48 Million | -24.44 Million | -10.34 Million |
| Earnings Before Tax Margin | -2.95 | -3.87 | -111.22 | -0.18 | -30.15 | -0.55 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 6.17 Million | 5.35 Million | 6.32 Million | 24.35 Million | 5.95 Million | 6.2 Million |
| Cost of Revenue | 778 Thousand | 652 Thousand | 927 Thousand | 2.8 Million | 697 Thousand | 656 Thousand |
| Gross Profit | 5.4 Million | 4.7 Million | 5.39 Million | 21.54 Million | 5.26 Million | 5.54 Million |
| Operating Expenses | 20.98 Million | 24.21 Million | 23.11 Million | 93.47 Million | 23.8 Million | 25.09 Million |
| Selling, General and Administrative Expenses | 7.89 Million | 10.62 Million | 10.34 Million | - | 11.22 Million | 11.77 Million |
| Research and Development Expenses | 13.09 Million | 13.59 Million | 12.76 Million | - | 11.89 Million | 13.31 Million |
| Other Expenses | 778 Thousand | 652 Thousand | 927 Thousand | 2.8 Million | 697 Thousand | 656 Thousand |
| Cost and Expenses | 21.76 Million | 24.86 Million | 24.04 Million | 96.28 Million | 23.8 Million | 25.74 Million |
| Operating Income | -15.58 Million | -19.51 Million | -17.71 Million | -71.93 Million | -17.84 Million | -19.54 Million |
| Interest Expense | 58 Thousand | 58 Thousand | 57 Thousand | 231 Thousand | -58 Thousand | 58 Thousand |
| Income Tax Expense | 1.06 Million | 6724.00 | -1.00 | 1105.00 | -44 Thousand | 15 Thousand |
| Earnings before Tax | -14.58 Million | -18.28 Million | -16.26 Million | -65.76 Million | -16.3 Million | -17.97 Million |
| Net Income | -14.58 Million | -18.28 Million | -16.26 Million | -65.76 Million | -16.3 Million | -17.97 Million |
| Earnings Per Share Basic | -0.54 | -0.68 | -0.60 | - | -0.60 | -0.67 |
| Earnings Per Share Diluted | -0.54 | -0.68 | -0.60 | - | -0.60 | -0.67 |
| Weighted Average Shares Outstanding | 27.01 Million | 26.98 Million | 26.96 Million | 26.91 Million | 26.94 Million | 26.87 Million |
| Weighted Average Shares Outstanding (Diluted) | 27.01 Million | 26.98 Million | 26.96 Million | 26.91 Million | 26.94 Million | 26.87 Million |
| Gross Margin | 0.87 | 0.88 | 0.85 | 0.88 | 0.88 | 0.89 |
| EBIT Margin | -2.34 | -3.64 | -2.79 | - | -3.00 | -2.89 |
| Profit Margin | -2.36 | -3.42 | -2.57 | -2.70 | -2.74 | -2.90 |
| EBITDA | -14.47 Million | -19.46 Million | -17.67 Million | - | -17.84 Million | -17.91 Million |
| Earnings Before Tax Margin | -2.52 | -3.65 | -2.80 | -2.95 | -3.00 | -3.15 |
PKTEF
ATHHF
000089
SAINTGOBAIN
HIPO-WT
UCSO